Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cells
Tóm tắt
The RNA binding protein, DEAD END (DND1), is essential for maintaining viable germ cells in vertebrates. It is also a testicular germ cell tumor susceptibility factor in mice. DND1 has been shown to interact with the 3'-untranslated region (3'-UTR) of mRNAs such as P27 and LATS2. Binding of DND1 to the 3'-UTRs of these transcripts blocks the inhibitory function of microRNAs (miRNA) from these transcripts and in this way DND1 helps maintain P27 and LATS2 protein expression. We found that DND1 is also expressed in embryonic stem (ES) cells. Because ES cells share similar gene expression patterns as germ cells, we utilized ES cells to identify additional candidate mRNAs that associate with DND1. ES cells are readily amenable to genetic modification and easier to culture in vitro compared to germ cells. Therefore, for the purpose of our study, we made a genetically modified, stable, human embryonic stem (hES) cell line that expresses hemagluttinin (HA)-tagged DND1 in a doxycycline (dox) regulatable manner. This line expresses modest levels of HA-DND1 and serves as a good system to study DND1 function in vitro. We used this stable cell line to identify the transcripts that physically interact with DND1. By performing ribonucleoprotein immunoprecipitation (RIP) followed by RT-PCR, we identified that transcripts encoding pluripotency factors (OCT4, SOX2, NANOG, LIN28), cell cycle regulators (TP53, LATS2) and apoptotic factors (BCLX, BAX) are specifically associated with the HA-DND1 ribonucleoprotein complex. Surprisingly, in many cases, bioinformatics analysis of the pulled-down transcripts did not reveal the presence of known DND1 interacting motifs. Our results indicate that the inducible ES cell line system serves as a suitable in vitro system to identify the mRNA targets of DND1. The RIP-RT results hint at the broad spectrum of mRNA targets that interact with DND1 in ES cells. Based on what is known about DND1 function, our results suggest that DND1 may impose another level of translational regulation to modulate expression of critical factors in ES cells.
Tài liệu tham khảo
Weidinger G, Stebler J, Slanchev K, Dumstrei K, Wise C, Lovell-Badge R, Thisse C, Thisse B, Raz E: dead end, a novel vertebrate germ plasm component, is required for zebrafish primordial germ cell migration and survival. Curr Biol. 2003, 13 (16): 1429-1434. 10.1016/S0960-9822(03)00537-2
Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML, Lamb BT, Deng JM, Behringer RR, Capel B: The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature. 2005, 435: 360-364. 10.1038/nature03595
Hayashi K, de Sousa Lopes SMC, Surani MA: Germ cell specification in mice. Science. 2007, 314: 394-396.
Saga Y: Mouse germ cell development during embryogenesis. Curr Opin Genet Dev. 2008, 18: 337-341. 10.1016/j.gde.2008.06.003
Noguchi T, Stevens LC: Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J Natl Cancer Inst. 1982, 69 (4): 907-913.
Noguchi T, Noguchi M: A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J Natl Cancer Inst. 1985, 75 (2): 385-392.
Stevens LC: A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst. 1973, 50 (1): 235-242.
Oosterhuis JW, Looijenga LHJ: Testicular germ-cell tumours in a broader perspective. Nature Rev Cancer. 2005, 5: 210-222. 10.1038/nrc1568.
Rescorla FJ: Pediatric germ cell tumors. Semin Surgical Oncology. 1999, 16: 144-158. 10.1002/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.0.CO;2-M.
Slanchev K, Stebler J, Goudarzi M, Cojocaru V, Weidinger G, Raz E: Control of dead end localization and activity - implications for the function of the protein in antagonizing miRNA function. Mech Dev. 2009, 126: 270-277. 10.1016/j.mod.2008.10.006
Kedde M, Strasser MJ, Boldajipour B, Vrielink JA, Slanchev K, le Sage C, Nagel R, Voorhoeve PM, van Duijse J, Orom UA: RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA. Cell. 2007, 131: 1273-1286. 10.1016/j.cell.2007.11.034
Linger R, Dudakia D, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G: Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer. 2008, 47: 247-252. 10.1002/gcc.20526
Ketting RF: A Dead End for MicroRNAs. Cell. 2007, 131: 1226-1227. 10.1016/j.cell.2007.12.004
Bhattacharya C, Aggarwal S, Zhu R, Kumar M, Zhao M, Meistrich ML, Matin A: The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. Biochem Biophys Res Commun. 2007, 355: 194-199. 10.1016/j.bbrc.2007.01.138
Yabuta Y, Kurimoto K, Ohinata Y, Seki Y, Saitou M: Gene expression dynamics during germline specification in mice identified by quantitative single-cell gene expression profiling. Biol Reprod. 2006, 75: 705-716. 10.1095/biolreprod.106.053686
Dyce PW, Toms D, Li J: Stem cells and germ cells: microRNA and gene expression signatures. Histol Histopathol. 2010, 25 (4): 505-513.
Chen C, Ridzon D, Lee CT, Blake J, Sun Y, Strauss WM: Defining embryonic stem cell identity using differentition related microRNAs and their potential targets. Mamm Genome. 2007, 18: 316-327. 10.1007/s00335-007-9032-6
Houbaviy HB, Murray MF, Sharp PA: Embryonic stem cell-specific microRNAs. Dev Cell. 2003, 5: 351-358. 10.1016/S1534-5807(03)00227-2
Houbaviy HB, Dennis L, Jaenisch R, Sharp PA: Characterization of a highly variable eutherian microRNA gene. RNA. 2005, 11: 1245-1257. 10.1261/rna.2890305
Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R: Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet. 2008, 40: 1478-1483. 10.1038/ng.250
Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E, Leffers H: Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res. 2004, 64: 4736-4743. 10.1158/0008-5472.CAN-04-0679
Elliott AM, de Miguel MP, Rebel VI, Donovan PJ: Identifying genes differentially expressed between PGCs and ES cells reveals a role for CREB-binding protein in germ cell survival. Dev Biol. 2007, 311: 347-358. 10.1016/j.ydbio.2007.08.029
Clark AT: The Stem Cell Identity of Testicular Cancer. Stem Cell Rev. 2007, 3: 49-59. 10.1007/s12015-007-0002-x
Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA: Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA. 2003, 100: 13350-13355. 10.1073/pnas.2235735100
Zwaka TP, Thomson JA: A germ cell origin of embryonic stem cells?. Development. 2005, 132: 227-233. 10.1242/dev.01586
Liu Y, Shin S, Zeng X, Zhan M, Gonzalez R, Mueller F-J, Schwartz CM, Xue H, Li H, Baker SC: Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Developmental Biology. 2006, 6: 20- 10.1186/1471-213X-6-20
Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppée F: An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 2008, 27: 2766-2779. 10.1038/emboj.2008.201
Agha-Mohammadi S, O'Malley M, Etemad A, Wang Z, Xiao X, Lotze MT: Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med. 2004, 6: 817-828. 10.1002/jgm.566
Keene JD, Komisarow JM, Friedersdorf MB: RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nature Protocols. 2006, 1 (1): 302-307. 10.1038/nprot.2006.47
Tai M-H, Chang C-C, Olson LK, Trosko JE: Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005, 26: 495-502.
Bourguignon LYW, Peyrollier K, Xia W, Gilad E: Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells. J Biol Chem. 2008, 283: 17635-17651. 10.1074/jbc.M800109200
Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS: Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer. 2008, 122: 1253-1260.
Voorhoeve PM, le Sage C, Schrier M, Gillis AJM, Stoop H, Nagel R, Liu Y-P, van Duijse J, Drost J, Griekspoor A: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006, 124: 1169-1181. 10.1016/j.cell.2006.02.037
Li CY, Chu JY, Yu JK, Huang XQ, Liu XJ, Shi L, Che YC, Xie JY: Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Research. 2004, 14: 473-479. 10.1038/sj.cr.7290250
Ting DT, Kyba M, Daley GQ: Inducible transgene expression in mouse stem cells. Methods Mol Med. 2005, 105: 23-46.
Kyba M, Perlingeiro RCR, Daley GQ: HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell. 2002, 109: 29-37. 10.1016/S0092-8674(02)00680-3
Townley-Tilson WHD, Pendergrass SA, Marzluff W, Whitfield ML: Genome-wide analysis of mRNAs bound to the histone stem-loop binding protein. RNA. 2006, 12: 1853-1867. 10.1261/rna.76006
Baroni TE, Chittur SV, George AD, Tenenbaum SA: Advances in RIP-chip analysis: RNA-binding protein immunoprecipitation-microarray profiling. Methods Mol Biol. 2008, 419: 93-108. 10.1007/978-1-59745-033-1_6
Chambers I, Smith A: Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 2004, 23: 7050-7160.
Niwa H: How is pluripotency determined and maintained?. Development. 2007, 134: 635-646. 10.1242/dev.02787
Silva J, Smith A: Capturing pluripotency. Cell. 2008, 132: 532-536. 10.1016/j.cell.2008.02.006
Cook MS, Munger SC, Nadeau JH, Capel B: Regulation of male germ cell cycle arrest and differentiation by DND1 is modulated by genetic background. Development. 2011
Almstrup K, Leffers H, Lothe RA, Skakkebaek NE, Sonne SB, Nielsen JE, Rajpert-De Meyts E, Skotheim RI: Improved gene expression signature of testicular carcinoma in situ. Int J Andrology. 2007, 30: 292-303. 10.1111/j.1365-2605.2007.00758.x.
Emerson RE, Ulbright TM: Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. Pathology. 2010, 42: 344-355. 10.3109/00313021003767355
Sonne SB, Perrett RM, Nielsen JE, Baxter MA, Kristensen DM, Leffers H, Hanley NA, Rajpert-De Meyts E: Analysis of SOX2 expression in developing human testis and germ cell neoplasia. Int J Dev Biol. 2010, 54: 755-760. 10.1387/ijdb.082668ss
Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, Mongan NP: Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the Nanog, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 2009, 18: 1093-1108. 10.1089/scd.2009.0113
Boheler KR: Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle. J Cell Physiol. 2009, 221: 10-17. 10.1002/jcp.21866